Cingulate Inc. Made Headway
Cingulate Inc. (CING:NASDAQ) soared at $1.85, a gain of 25%. On Fri, Mar 10, 2023, CING:NASDAQ touched a New 2-Week High of $1.85. The stock appeared on our News Catalysts scanner on Fri, Mar 10, 2023 at 04:59 PM in the 'BIOTECH' category. From Fri, Feb 24, 2023, the stock recorded 50.00% Up Days and 45.45% Green Days
The stock spiked on Fri, Feb 24, 2023 at $1.93 with a volume of 37M+.
About Cingulate Inc. (CING:NASDAQ)
Cingulate Inc is a clinical stage biopharmaceutical company utilizing its proprietary precision timed release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical...
Top 10 Gainers:
- Euda Health Holdings Ltd Ord Shs (EUDA:NASDAQ), 54.2%
- Cazoo Group Ltd Class A (CZOO:NYSE), 32.32%
- Unicycive Therapeutics Inc. (UNCY:NASDAQ), 30.1%
- SportsMap Tech Acquisition Corp. (SMAP:NASDAQ), 29.83%
- Boxed Inc. (BOXD:NYSE), 26.89%
- Cingulate Inc. (CING:NASDAQ), 25%
- Evoke Pharma, Inc. (EVOK:NASDAQ), 23.29%
- Tenax Therapeutics, Inc. (TENX:NASDAQ), 22.96%
- Solo Brands Inc. Class A (DTC:NYSE), 21.19%
- Altamira Therapeutics Ltd. (CYTO:NASDAQ), 20.93%